CI
NYSE · Health Care
The Cigna Group
$282.49
+7.24 (+2.63%)
CI News30 articles
Hims & Hers Shares Surge on Canaccord Upgrade Amid GLP-1 Shift
Hims & Hers shares climbed 9.5% to $37.97 after Canaccord Genuity raised its target to $40, reflecting a 25% bump. The company's GLP-1 strategy and Medicare's new Bridge program are reshaping the weight-loss drug market.
AI-Driven Healthcare Fraud Surge Strains Insurers, Coverage Gaps Widen
AI is fueling healthcare fraud with fake medical records and bot calls, driving up costs and exposing coverage gaps as insurers scramble to adapt.
UnitedHealth Rises as Analysts See Easing Medical Costs
UnitedHealth shares climbed 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target, citing easing medical costs and a favorable Q2 setup.
UnitedHealth Drops Premarket After Berkshire Exits Stake
UnitedHealth shares dropped 4.8% in premarket trading after Berkshire Hathaway disclosed it sold its stake in the insurer, dampening sentiment despite strong Q1 results.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
Blue Cross Blue Shield $2.67B Settlement Payouts Begin in May 2026
Blue Cross Blue Shield settlement payments start in May 2026 for eligible claimants in a $2.67 billion antitrust case. Payouts vary based on claims and premiums, with an estimated average of $333.
Cigna Exits ACA Market, 369,000 Members Need New Plans for 2027
Cigna Group will exit the ACA individual insurance market after 2026, affecting 369,000 members in 11 states who must find new coverage for 2027.
Blue Cross Blue Shield Settlement Payouts to Begin in May
Payments from the $2.67 billion Blue Cross Blue Shield antitrust settlement begin in May 2026 for eligible claimants who filed by November 2021.
UnitedHealth Shares Drop Ahead of Q1 Report, Sector Under Pressure
UnitedHealth Group shares declined sharply Friday, extending weekly losses as the market anticipates first-quarter results. The health insurance sector broadly retreated.
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
BitMine Stock Climbs 9% Despite Ether Dominance in Asset Mix
BitMine (NYSE:BMNR) shares rose 9% this week, but its $4B buyback program is overshadowed by massive Ethereum holdings. Ether price swings dwarf repurchase impact.
NuScale Power Gains Despite Revenue Collapse as Cash Position Strengthens
NuScale Power shares climbed 3.7% to $9.82 despite a 99.1% revenue drop, as investors focused on a $1.89B cash position and ongoing strategic progress.
Hertz Stock Soars 29% on Q2 Beat, But Q3 Is the Real Test
Hertz (HTZ) surged 29.5% after beating Q2 earnings estimates, but the full-year forecast depends on Q3. Short covering and strong pricing drove the rally.
Dow Drops 370 Points as Five Stocks Drive Most of the Decline
The Dow Jones Industrial Average fell 370 points, with five stocks accounting for 59% of the decline. Broader markets showed resilience, suggesting sector rotation.
Ford Stock Rises Despite July Sales Drop as Truck Mix Strengthens
Ford (F) shares rose 1.1% despite a 10.2% July sales drop, as trucks gained share and the company raised its 2026 outlook. Truck mix hit 63%.
SoFi's Rebound Puts the Spotlight on Its Ambitious H2 Margin Target
SoFi Technologies (NASDAQ:SOFI) has fully recovered its post-earnings losses, but the stock's rally hinges on the company's ability to deliver a sharp margin expansion in the second half of 2026.
Uber's Cash Conversion Under the Microscope Ahead of Q2 Results
Uber (UBER) reports Q2 earnings amid concerns that booking growth isn't translating into cash, as it prepares a $14.8B Delivery Hero acquisition.
TG Therapeutics Stock Drops 9.8% Despite Strong BRIUMVI Sales as Costs Surge
TG Therapeutics shares fell 9.8% as Q2 revenue rose 70% but operating income declined 38% on surging costs. Guidance raised modestly.
AZN-BMY Merger Talks: A $455B Pharma Mega-Deal in the Making?
AstraZeneca and Bristol Myers Squibb are reportedly in merger talks, which could create a $455 billion pharmaceutical giant. Reuters has not confirmed the report.
BitMine Stock Gains 9% Weekly Despite Ether Flat; NAV Discount Narrows
BMNR climbed 9.4% for the week despite a 2.8% drop in Ether. NAV stands at $18.12-$18.48, with shares trading at a discount.
Netflix Slips After $500M Licensing Deal for The Walking Dead Franchise
Netflix shares slipped 0.6% after announcing a $500 million, five-year licensing deal for The Walking Dead franchise, raising questions about the impact on its ad-supported model and overall content spending.
Dow Gains 300 Points, But Microsoft Alone Drives the Rally
The Dow Jones rose 304 points on July 30, 2026, but Microsoft alone accounted for 356 points of the gain, masking weakness in other sectors.
Qantas Project Sunrise Test Flight Success Puts Premium Pricing Strategy to the Test
Qantas cleared a key endurance test for Project Sunrise, but the commercial viability depends on selling 98 premium seats at premium prices.
Microsoft Azure Growth Surprises to the Upside, Easing AI Spending Fears
Microsoft shares gained about 3% in extended trading after Azure revenue surged 43%, surpassing consensus estimates and alleviating market worries about the company's massive AI infrastructure spending.
Oil Spike and Fed Jitters Drag Dow 852 Points; Two Stocks Account for Most of the Drop
US stocks slid midday Wednesday, with the Dow down 852 points, as oil prices surged and the Fed decision approached. Two high-priced components accounted for most of the drop.
Spider-Man Sequel's Record Projection Sparks Theater Stock Rally
Spider-Man: Brand New Day's projected $195M-$250M U.S.-Canada opening could boost theater stocks. Cinemark reports earnings Thursday; Sony releases the film Friday.
From Dive Sites to Air Force One: The Vast Price Gap in Retired 747s
Retired 747s range from a $100,000 reef-destined jet to a $200 million U.S. support aircraft. Boeing (BA) shares edged up 1.2% as services margins outpaced defense. Earnings due Tuesday.
Capricor Therapeutics Plunges 67% on FDA Concerns Over Deramiocel Efficacy
Capricor Therapeutics shares plummeted 67% after FDA staff flagged concerns about deramiocel's efficacy data, wiping out $766 million in market value ahead of a key advisory committee vote.
BitMine Shares Jump 13% on Buyback That Boosts Ether Per Share
BitMine (BMNR) shares climbed 12.8% to $17.81 after the company's buyback program drove a 1.2% increase in ether per share, with repurchases accounting for 86% of the gain.